Aberrant intermediate alveolar epithelial cells promote pathogenic activation of lung fibroblasts in preclinical fibrosis models.
Saved in:
| Title: | Aberrant intermediate alveolar epithelial cells promote pathogenic activation of lung fibroblasts in preclinical fibrosis models. |
|---|---|
| Authors: | Hoffman ET; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Shah A; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Barboza WR; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Rodriguez LR; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Dherwani R; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Dooley PE; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.; The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Minakin K; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.; The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Tomer Y; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Ayers LJ; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.; The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Jones D; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.; The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Murthy A; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Bennett A; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Lange AN; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA., Bawa PS; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA., Wang F; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA., Babu A; PENN -CHOP Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, USA., Chavez K; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Nakamoto RS; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Cooper CH; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA., Basil MC; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA.; PENN -CHOP Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, USA., Raredon MSB; Department of Anesthesiology, Yale School of Medicine, New Haven, CT, USA.; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.; Program in Translational Biomedicine (PTB), Yale School of Medicine, New Haven, CT, USA., Kotton DN; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.; The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Alysandratos KD; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.; The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Katzen J; Pulmonary, Allergy, and Critical Care Medicine Division, University of Pennsylvania, Philadelphia, PA, USA. Jeremy.Katzen@pennmedicine.upenn.edu.; PENN -CHOP Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, USA. Jeremy.Katzen@pennmedicine.upenn.edu. |
| Source: | Nature communications [Nat Commun] 2025 Sep 30; Vol. 16 (1), pp. 8710. Date of Electronic Publication: 2025 Sep 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-63735-1 |
